• Tue, March 1, 2022

by: WOPRAI

Scott Berg Maintained (WDAY) at Strong Buy with Decreased Target to $300 on, Mar 1st, 2022

by: WOPRAI

Richard Nguyen Upgraded (WDAY) to Strong Buy on, Mar 1st, 2022

by: WOPRAI

Derrick Wood Maintained (WDAY) at Buy with Increased Target to $310 on, Mar 1st, 2022

by: WOPRAI

Joshua Pokrzywinski Upgraded (WMS) to Buy and Held Target at $145 on, Mar 1st, 2022

by: WOPRAI

Selman Akyol Maintained (WMB) at Strong Buy with Increased Target to $34 on, Mar 1st, 2022

by: WOPRAI

Kunaal Malde Downgraded (WIX) to Hold and Held Target at $100 on, Mar 1st, 2022

by: WOPRAI

Stephanie Yee Initiated (WM) at Hold and Held Target at $153 on, Mar 1st, 2022

by: WOPRAI

Taylor Zurcher Downgraded (WHD) to Hold on, Mar 1st, 2022

by: WOPRAI

Jason Cassorla Maintained (UHS) at Strong Buy with Increased Target to $167 on, Mar 1st, 2022

by: WOPRAI

Joshua Pokrzywinski Maintained (TT) at Buy with Decreased Target to $190 on, Mar 1st, 2022

by: WOPRAI

Mark Zgutowicz Initiated (TTD) at Hold on, Mar 1st, 2022

by: WOPRAI

Matt Miksic Maintained (XRAY) at Buy with Decreased Target to $67 on, Mar 1st, 2022

by: WOPRAI

Nathan Rich Maintained (XRAY) at Hold with Decreased Target to $59 on, Mar 1st, 2022

by: WOPRAI

Daniel Perlin Maintained (TASK) at Buy with Decreased Target to $46 on, Mar 1st, 2022

by: WOPRAI

Brian Essex Maintained (TASK) at Strong Buy with Decreased Target to $66 on, Mar 1st, 2022

by: WOPRAI

Joshua Pokrzywinski Maintained (SWIM) at Hold with Decreased Target to $21 on, Mar 1st, 2022

by: WOPRAI

Jamie Perse Initiated (THC) at Strong Buy on, Mar 1st, 2022

by: WOPRAI

Peter Benedict Maintained (TGT) at Buy and Held Target at $275 on, Mar 1st, 2022

by: WOPRAI

Stanley Elliott Maintained (TREX) at Strong Buy with Decreased Target to $120 on, Mar 1st, 2022

by: WOPRAI

Yanan Zhu Initiated (TSHA) at Buy and Held Target at $25 on, Mar 1st, 2022

by: WOPRAI

Paul Fremont Initiated (CEG) at Hold and Held Target at $46 on, Mar 1st, 2022

by: WOPRAI

Mark Zgutowicz Initiated (SNAP) at Strong Buy and Held Target at $50 on, Mar 1st, 2022

by: WOPRAI

Colin Sebastian Maintained (BABA) at Buy with Decreased Target to $160 on, Mar 1st, 2022

by: WOPRAI

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $27 on, Mar 1st, 2022

by: WOPRAI

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $9 on, Mar 1st, 2022

by: WOPRAI

David Lebowitz Initiated (ASND) at Strong Buy and Held Target at $187 on, Mar 1st, 2022

by: WOPRAI

Joshua Pokrzywinski Maintained (CARR) at Buy with Increased Target to $55 on, Mar 1st, 2022

by: WOPRAI

Bradley Canino Maintained (ALXO) at Strong Buy with Decreased Target to $36 on, Mar 1st, 2022

by: WOPRAI

David Lebowitz Initiated (ALNY) at Strong Buy and Held Target at $223 on, Mar 1st, 2022

by: WOPRAI

Andrew Mok Upgraded (AMED) to Hold and Increased Target to $168 on, Mar 1st, 2022

by: WOPRAI

John Vinh Maintained (AMBA) at Buy with Decreased Target to $160 on, Mar 1st, 2022

by: WOPRAI

Quinn Bolton Maintained (AMBA) at Strong Buy with Decreased Target to $175 on, Mar 1st, 2022

by: WOPRAI

Kevin Cassidy Maintained (AMBA) at Strong Buy with Decreased Target to $200 on, Mar 1st, 2022

by: WOPRAI

Gary Mobley Maintained (AMBA) at Buy with Decreased Target to $175 on, Mar 1st, 2022

by: WOPRAI

Joseph Moore Maintained (AMBA) at Buy with Decreased Target to $164 on, Mar 1st, 2022

by: WOPRAI

Tore Svanberg Maintained (AMBA) at Strong Buy with Decreased Target to $190 on, Mar 1st, 2022

by: WOPRAI

Richard Shannon Maintained (AMBA) at Strong Buy with Decreased Target to $170 on, Mar 1st, 2022

by: WOPRAI

David Lebowitz Initiated (BPMC) at Hold on, Mar 1st, 2022

by: WOPRAI

John Gerdes Maintained (BP) at Strong Buy with Decreased Target to $42 on, Mar 1st, 2022

by: WOPRAI

Jason Gerberry Initiated (ACLX) at Strong Buy and Held Target at $24 on, Mar 1st, 2022

by: WOPRAI

Daina Graybosch Initiated (ACLX) at Buy and Held Target at $47 on, Mar 1st, 2022

by: WOPRAI

Whit Mayo Maintained (ACHC) at Buy with Decreased Target to $80 on, Mar 1st, 2022

by: WOPRAI

Jason Butler Maintained (ACAD) at Buy with Decreased Target to $35 on, Mar 1st, 2022

by: WOPRAI

Tazeen Ahmad Maintained (ACAD) at Hold with Decreased Target to $31 on, Mar 1st, 2022

by: WOPRAI

Andrew Baum Reiterated (ABBV) at Strong Buy with Increased Target to $170 on, Mar 1st, 2022

by: WOPRAI

Matt Miksic Initiated (ZIMV) at Sell and Held Target at $34 on, Mar 1st, 2022

by: WOPRAI

Kash Rangan Maintained (ZM) at Hold with Decreased Target to $171 on, Mar 1st, 2022

by: WOPRAI

Parker Lane Maintained (ZM) at Hold with Decreased Target to $150 on, Mar 1st, 2022

Bradley Canino Maintained (ALXO) at Strong Buy with Decreased Target to $36 on, Mar 1st, 2022

Bradley Canino of Stifel, Maintained "ALX Oncology Holdings Inc." (ALXO) at Strong Buy with Decreased Target from $60 to $36 on, Mar 1st, 2022.

Bradley has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, all agrees with Bradley's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Wednesday, December 22nd, 2021

Like: 👍